European Handbook of Neurological Management 2011
DOI: 10.1002/9781444346268.ch14
|View full text |Cite
|
Sign up to set email alerts
|

Neuroimaging in the Management of Motor Neuron Diseases

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
2
0

Year Published

2017
2017
2023
2023

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 116 publications
0
2
0
Order By: Relevance
“…As a result, while MR imaging of the brain is currently used to exclude mimic pathology and the detection of the T2 hypointensity of M1 can support suspicion of ALS, the specific search for this abnormality is not recommended for ALS diagnosis. 12 The first attempt to move toward the radiologic diagnosis at the single-subject level was recently performed with an ultrahigh-field MR imaging system (7T). 13 Taking advantage of the very high sensitivity of ultra-high-field strength to the magnetic susceptibility of microglial ferritin, the authors localized pathologic cortical thinning and T2* hypointensity in the deep layers of M1, and they were shown to significantly correlate with the clinical UMN burden.…”
mentioning
confidence: 99%
“…As a result, while MR imaging of the brain is currently used to exclude mimic pathology and the detection of the T2 hypointensity of M1 can support suspicion of ALS, the specific search for this abnormality is not recommended for ALS diagnosis. 12 The first attempt to move toward the radiologic diagnosis at the single-subject level was recently performed with an ultrahigh-field MR imaging system (7T). 13 Taking advantage of the very high sensitivity of ultra-high-field strength to the magnetic susceptibility of microglial ferritin, the authors localized pathologic cortical thinning and T2* hypointensity in the deep layers of M1, and they were shown to significantly correlate with the clinical UMN burden.…”
mentioning
confidence: 99%
“…It has been found that many neurological disorders such as major depressive disorder (MDD) [4,5], Alzheimer's disease (AD) [6,7], Parkinson's disease (PD) [8], and cerebrovascular dysfunction diseases [9] are closely related to OA and may be comorbidities or risk factors for it. Neuroimaging techniques have been utilized in recent years for the non-invasive detection of central and peripheral nervous system degeneration so as to monitor disease progression and prognosis, and it has also been applied to investigate brain structure, function and metabolism [10,11]. It is also worth noting that these disorders usually have neurological degeneration to certain extent.…”
Section: Introductionmentioning
confidence: 99%